Life as a Nephrology Professional National Kidney Foundation

Utilizing a creative and interactive approach within an interdisciplinary team promotes easy conversation around difficult topics such as advance care planning. Effective communication between team members and with patients helps increase awareness of this critical topic. Join our host and guests in a discussion focused on why, despite the availability of numerous tools designed to assist professionals in guiding patients through the process of planning for future healthcare needs, a noticeable gap persists between our aspirations and the current reality.
Learn more on this topic from the SCM24 abstract, Promoting Advance Care Planning Among Patients with Chronic Kidney Disease, published in April 2024 in the Journal of Nephrology Social Work.
 
Host: Raphy Rosen, MD
Guests: Michelle Rowlett, MSW, LICSW & Grace Scarborough, RDN, CD

Join us in this episode as we explore the intriguing world of pediatric kidney health with Dr. Casey Rebholz, an esteemed expert in epidemiology and clinical research. Discover recent insights from the Journal of Renal Nutrition (linked here) regarding the impact of dietary protein-rich foods on kidney disease progression in children. Dr. Rebholz shares valuable perspectives on the significance of protein metabolites, the importance of metabolite testing, and effective strategies for preserving renal function in pediatric patients with chronic kidney disease (CKD). Tune in for a deep dive into protecting and optimizing kidney health in our young population. 
Host: Osama El Shamy, MDContributor: Casey Rebholz, PhD, MS, MNSP, MPH

Kidney transplants are a life-changing intervention, but do not work immediately; this delayed graft function has serious implications for transplant programs, patient outcomes, and organ waste. Tune in as our host Dr. Anna Gaddy interviews Dr. Matthew Cooper to discuss the research and implications behind his co-authored special report, “Understanding Delayed Graft Function to Improve Organ Utilization and Patient Outcomes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation”, published in the March 2024 issue of AJKD.
Kidney transplant care teams can work collaboratively to say ‘yes’ to transplant and decrease the number of viable kidneys that are otherwise discarded. Read the article, listen in, and bring this important conversation to your kidney transplant community.
Host: Anna Gaddy, MD, FASN, FNKFContributor: Matthew Cooper, MD, FACS, FAST, FNKF

Experience a dynamic panel discussion on advancing kidney health equity and increasing access to transplants in our recorded webinar, presented by the NKF and National MOTTEP. 
In 2021, there were 786,000 patients living with kidney failure, yet fewer than 25,000 received a transplant that year. Black people are more than 4 times as likely as White people to have kidney failure. To help address these disparities, the NKF and National MOTTEP (Minority Organ Tissue Transplant Education Program) are teaming up to educate on the importance of building trustworthiness and community partnerships to advance kidney health equity and increase access to transplants for all.
Panelists: Clive O. Callender, MD; Kirk Campbell, MD, FASN; Karim Ali, SA; Tanjala S. Purnell, PhD, MPH, FASN; Morgan Reid, MSJ; Velma Scantlebury, MD, FACS, GCM

In part two of this 2-episode mini-series, our panelists discuss the recent approval of tenapanor for hyperphosphatemia management in patients on dialysis by the United States Food & Drug Administration (FDA). Tune into this discussion where our expert panelists share how the phosphate absorption inhibitor (PAI) works, factors to consider when integrating this agent into a patient’s treatment regimen, and how it may impact hyperphosphatemia management moving forward.
Learning objectives:
Describe the primary pathways for phosphate absorption.
Explain the potential role(s) for a phosphate absorption inhibitor (PAI) for people with CKD who are on dialysis.
Host: Sam Kant, MDGuests: Alexander Leidner, MD; Annabel Biruete, RD, PhD; Alex Berrios
Supported by a grant from Ardelyx.
Don't miss Part 1 in this series! Listen to: Patient & Clinician Experiences with Hyperphosphatemia: The Current Landscape

In part one of this 2-episode mini-series, our panelists discuss the current landscape of hyperphosphatemia management for patients on dialysis – including what’s working well and where there is room for improvement. Tune into this discussion where our experts share their experiences with leveraging team-based and person-centered approaches to managing hyperphosphatemia from the perspectives of nephrologist, dietitian, and patient.
Learning objectives:
Identify the consequences of elevated serum phosphate levels.
Recognize the stigma patients experience as a result of not achieving their serum phosphate target level.
Host: Sam Kant, MDGuests: Alexander Leidner, MD; Annabel Biruete, RD, PhD; Alex Berrios
Supported by a grant from Ardelyx.
Don't miss Part 2 in this series! Listen to: Hyperphosphatemia Treatment Innovations: Phosphate Absorption Inhibitor (PAI)